Abstract

In this paper, we propose a free final time optimal control approach applied to 4 ordinary differential equations which describe the tumor‐immune interactions after the injection of the bacillus Calmette‐Guérin (BCG) in the bladder of a hypothetical patient. The main goal of this optimal control strategy is to find the optimal dosage amount needed in each instillation of BCG for stimulating the immune‐system and then killing superficial bladder tumors and to determine the optimal duration of treatment, adequate for stopping the intravesical therapy with lesser side‐effects. For this, we introduce into the model of interest, a control function which represents the dose of BCG immunotherapy procedure and we formulate a minimization problem where the final time is considered free (nonfixed). The characterization of the sought optimal control noted u∗ is derived based on Pontryagin's maximum principle, while the formulation of the sought optimal final time noted is based on formulae of sensitivity which are obtained conditions from the derivative of the objective function with respect to . We investigate the resolution of the free final time optimal control problem in 3 possible cases: (a) when is quadratic in the final gain function, (b) when the final gain function does not depend on , and (c) when is linear in the final gain function. Finally, we obtain the sought optimal dose of BCG, and we conclude that in case (a), we obtain an optimal duration which is more beneficial regarding the activation of immune cells while cases (b) and (c) both provide an optimal duration which is more adequate for the minimization of the tumoral population.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.